Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 3 The BDNF level for MS patients in remission, MS patients in relapse, and control groups

From: Serum level of brain-derived neurotrophic factor in patients with relapsing–remitting multiple sclerosis: a potential biomarker for disease activity

  MS cases in remission (n = 30) MS cases in relapse (n = 30) Control (n = 30) P value
  Median Q1 Q3 Median Q1 Q3 Median Q1 Q3  
BDNF (pg/ml) 225 200 325 310 250 950 248 220 325 0.006*
  1. BDNF brain-derived neurotrophic factor
  2. *P value < 0.05 (significant)
Back to article page